SBC Medical Group Holdings Incorporated Increase (Decrease) in Leasing Receivables
SBC Medical Group Holdings Incorporated (SBC) reported Increase (Decrease) in Leasing Receivables of -$247.19 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLeasingReceivables · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for the quarter ending 2026-06-30 was $17.06K, a 99.54% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for the quarter ending 2026-03-31 was -$264.25K, a 109.51% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for the quarter ending 2025-12-31 was $3.52M, a 37.41% increase year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for the quarter ending 2025-09-30 was $2.74M, a 64.28% increase year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for fiscal 2025 was $12.75M, a 112.75% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for fiscal 2024 was $5.99M.
- SBC Medical Group Holdings Incorporated increase (decrease) in leasing receivables for fiscal 2023 was -$16.58M.
| Period end | Increase (Decrease) in Leasing Receivables 3 month | Increase (Decrease) in Leasing Receivables 6 month | Increase (Decrease) in Leasing Receivables 9 month | Increase (Decrease) in Leasing Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$247.19K 10-Q · filed 2026-08-13 | $3.27M derived: sum of 3 quarters · filed 2026-08-13 | $6.02M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$264.25K 10-Q · filed 2026-05-14 | $3.25M derived: sum of 2 quarters · filed 2026-05-14 | $6.00M derived: sum of 3 quarters · filed 2026-05-14 | $9.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $6.26M derived: sum of 2 quarters · filed 2026-03-27 | $9.97M derived: sum of 3 quarters · filed 2026-08-13 | $12.75M 10-K · filed 2026-03-27 |
| 2025-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.45M derived: sum of 2 quarters · filed 2026-08-13 | $9.23M 10-Q · filed 2025-11-14 | $11.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.48M 10-Q · filed 2026-08-13 | $9.04M derived: sum of 3 quarters · filed 2026-08-13 | $10.71M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.78M 10-Q · filed 2026-05-14 | $5.34M derived: sum of 2 quarters · filed 2026-05-14 | $7.01M derived: sum of 3 quarters · filed 2026-05-14 | $7.96M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $4.23M derived: sum of 2 quarters · filed 2026-03-27 | $5.18M derived: sum of 3 quarters · filed 2026-03-27 | $5.99M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.62M derived: sum of 2 quarters · filed 2025-11-14 | $3.43M 10-Q · filed 2025-11-14 | $4.10M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $944.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.76M 10-Q · filed 2025-08-13 | $2.43M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $814.61K 10-Q · filed 2025-05-15 | $1.48M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $666.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$16.58M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$17.24M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |